Loading…

Production of recombinant xenotransplantation antigen in Escherichia coli

The synthesis of sufficient amounts of oligosaccharides is the bottleneck for the study of their biological function and their possible use as drug. As an alternative for chemical synthesis, we propose to use Escherichia coli as a “living factory.” We have addressed the production of the Gal pα(1–3)...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2003-03, Vol.302 (3), p.620-624
Main Authors: Bettler, Emmanuel, Imberty, Anne, Priem, Bernard, Chazalet, Valérie, Heyraud, Alain, Joziasse, David H, Geremia, Roberto A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The synthesis of sufficient amounts of oligosaccharides is the bottleneck for the study of their biological function and their possible use as drug. As an alternative for chemical synthesis, we propose to use Escherichia coli as a “living factory.” We have addressed the production of the Gal pα(1–3)Gal pβ(1–4)GlcNAc epitope, the major porcine antigen responsible for xenograft rejection. An E. coli strain was generated which simultaneously expresses NodC (to provide the chitin-pentaose acceptor), β(1–4) galactosyltransferase LgtB, and bovine α(1–3) galactosyltransferase GstA. This strain produced 0.68 g/L of the heptasaccharide Gal pα(1–3)Gal pβ(1–4)(GlcNAc) 5, which harbours the xenoantigen at its non-reducing end, establishing the feasibility of this approach.
ISSN:0006-291X
1090-2104
DOI:10.1016/S0006-291X(03)00227-4